Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BlackPeak Capital is a private equity and growth equity investment firm focused on backing companies in Southeast Europe. It is not a biotechnology, pharmaceutical, or healthcare operating company; rather, it invests across sectors and has participated in selected healthcare-related deals such as genetic testing and elderly care services. The firm supports growth-stage businesses with capital and strategic guidance. Public materials describe its investor base as including institutions such as the European Investment Fund, the European Bank for Reconstruction and Development, the International Finance Corporation, as well as pension funds, family offices, and other financial institutions. For a biotech analyst, BlackPeak Capital is best understood as a regional financial sponsor and investor, not a therapeutic product developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BlackPeak Capital.